- 6 DSOs entering new states
- Ohio legislature targets healthcare noncompetes
- Select Medical, Carilion Clinic to build Virginia rehab hospital
- The future of the anesthesiologist-CRNA relationship
- Meet the CEOs of 10 specialty DSOs
- Autism therapy boom strains Medicaid budgets: 5 notes
- 4 medical device recalls to know
- South Dakota system to rebrand post-Sanford Health merger
- UW Medicine partners on imaging for cancer care
- 4 Massachusetts hospitals, universities to open nurse apprenticeships
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- No ‘certain’ COVID-19 vaccine link to child deaths: FDA
- Mental disorders affect 1.2 billion people worldwide: 5 things to know
- FDA approves 1st chronic HDV treatment
- New Hampshire hospital expands Afib care with 2 new programs
- Louisiana universities partner on pharmacy training pathway
- UHS behavioral health president resigns
- Tennessee system plans $23M ASC after joint venture falls through
- Travel nurse market shows signs of stabilization: Survey
- CareSource pauses behavioral health Medicaid clawbacks
- Anesthesiologist to lead Illinois physician society
- 10 highest-paying states for dental assistants
- 15 dentists making headlines
- How much are ASCs actually worth right now?
- Smile Partners USA enters Massachusetts, its 7th market
- California multispecialty specialty MSO inks deal with AI platform
- Listen to the Latest ‘KFF Health News Minute’
- DME fraud cases mount as federal scrutiny intensifies
- CVS sues to challenge Tennessee's new PBM law
- Staffing the Modern ASC: Managing Complexity, Expertise and Performance
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Dust Yields Clues to Viral Outbreaks, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod
- 3 Medical Routines That Older People May Not Need
- Cheaper, Alternative Health Plans Are Having a Moment, but Critics Urge Caution
- Acadia boosts ‘More To Parkinson's’ campaign with Ryan Reynolds, Parkinson’s voices
- Niowave kicks off construction of $75M radiopharmaceutical isotope plant in Michigan
- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- ADA proposes standards on dental cartridges, water quality
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- Dental Medicaid disenrollment could cause $86M in added costs
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Swoop acquires prescription fulfillment platform Nimble to support independent pharmacies
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Ipsen details growing pains as teens transition to adult care
- Real-World Evidence in the AI Era: What You Can Unlock Depends on What You Build On
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- Watch: The Tug-of-War Over Taxpayer Dollars
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Eliminating KRAS: Why targeted protein degraders could redefine what’s possible in cancer
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
Department of Health and Human Services Secretary Kennedy reconstituted the Interagency Autism Coordinating Committee (I-ACC) in January with 21 new public members. Now beginning their mandate, they have attacted a great deal of criticism from the establishment:
Kennedy's new US autism panel to examine potential causes
By Leah Douglas and Ahmed Aboulenein - March 5, 2026Summary
- New panel includes vaccine skeptics, raising concerns among autism experts
- Panel could explore controversial vaccine links
- Outside experts warn focus on vaccines may divert funds from other autism research
WASHINGTON, March 5 (Reuters) - A U.S. autism advisory board remade by Health Secretary Robert F. Kennedy Jr. to include vaccine skeptics aims to steer federal research spending toward investigating causes of the condition, as well as other issues like co-occurring medical disorders, according to some new panel members.
Kennedy, a longtime anti-vaccine activist who has suggested the inoculations cause autism, contrary to scientific evidence, reset the Interagency Autism Coordinating Committee in January with 21 new public members. More than a third of the new committee members have also promoted the debunked link between vaccines and autism.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Some autism experts, including former committee members, have said the new members could undermine federal autism research. This week, some former members created their own alternative advisory board, the latest in a series of similar efforts by public health experts concerned about Kennedy's overhaul of federal vaccine policy and what they see as misinformation coming from agencies he oversees.No rigorous studies have found links between autism and vaccines or medications. Autism experts attribute rising rates of the condition largely to more inclusive diagnosis criteria.
The committee, due to first meet on March 19, will provide non-binding guidance to Kennedy on federal autism research priorities, including recommendations on allocating hundreds of millions of dollars in research spending.
Kennedy has promised President Donald Trump he will identify the cause of autism, which most researchers suggest is linked in part to genetics and exposure in utero to pollutants or harmful contaminants. Many of Kennedy's supporters in the Make America Healthy Again movement - some of whom were named to the committee - also believe vaccines can cause autism and advocate for fewer childhood vaccinations.
Committee chair Sylvia Fogel, a psychiatrist and instructor at Harvard Medical School, told Reuters the committee will address gaps in autism research like causal triggers in an effort to better serve people with profound autism and their families.
"Autism is not monolithic. Federal strategy should reflect that complexity rather than flatten it," Fogel said.
Department of Health and Human Services spokesman Andrew Nixon said the new committee is meant to unite a range of voices and that "expanding perspectives on the panel does not change the fact that federal research is grounded in rigorous science."
SOME MEMBERS LINK VACCINES AND AUTISM
Until January's overhaul, major autism groups like the Simons Foundation and Autism Speaks, and researchers from universities including Johns Hopkins and Tufts accounted for most of the committee's 21 members from the public.
That panel recommended further research into co-occurring physical and behavioral health conditions, like epilepsy, gastrointestinal issues and anxiety disorders, according to a draft 2024 report.
David Sitcovsky, vice president of advocacy at Autism Speaks, said in a statement that broader representation would strengthen the committee, but that its impact would depend on retaining a grounding in science.
The new panel contains more activists, just three autistic self-advocates - the minimum required by law - down from seven, and few representatives from research universities. At least eight have tied vaccination to autism or are connected to organizations that support those claims, including several who say their children developed autism after being vaccinated, according to a Reuters review of their public statements and affiliations.
Panel member Ginger Taylor, who created a website called "How Do Vaccines Cause Autism?", wrote in a Substack post that her top priority for the committee is investigating the link between vaccines and autism.
John Gilmore, a new panel member and co-founder of the Autism Action Network who says his 26-year-old son developed autism after being vaccinated, said he wants to steer more research toward rising autism rates.
"A lot of the voices that are on the (committee) now have been deliberately excluded for 20-odd years," he said.
Several, including Gilmore and Fogel, appeared on panels at a September autism event hosted by the MAHA Institute, whose president, Mark Gorton, is an anti-vaccine activist and was a significant funder of Kennedy's 2024 presidential campaign.
Asked how some members' views on vaccines will affect the committee's work, Fogel said studies of the measles-mumps-rubella vaccine and thimerosal-containing vaccines have not shown a causal link to autism.
"That body of available evidence is substantial and must be acknowledged," Fogel said.
Still, research should examine how various exposures, including immune or inflammatory stress, might affect autism outcomes, she said.
EXPERT CONCERNS
On Tuesday, a dozen autism advocates, researchers and several former committee members formed the Independent Autism Coordination Committee to create its own strategic plan for autism research.
Alison Singer, president of the Autism Science Foundation and a prior government committee member, said investing federal dollars into researching a link between vaccines and autism, which most experts consider settled science, would cut into funding for other research opportunities, like autism's heritability or link to environmental exposures.
"There’s not a bottomless pit of money at the NIH that can be used to fund research," Singer said. "If we devote our very limited resources towards reinvestigating vaccines, we won’t have money to look at actual potential causes of autism."
More on the self appointed Independent Autism Coordinating Committee (I-ACC), with a deceitful name and acronym deliberately chosen to confuse the public into thinking that it is the official Interagency Autism Coordinating Committee (I-ACC):
Autism researchers rebuke Kennedy, form independent advisory group
The group wants to be a bulwark against potential misinformation from federal health agencies
By O. Rose Broderick - March 3, 2026A group of autism researchers and advocates announced Tuesday the formation of an independent advisory body that will develop a scientific agenda for the autism community. They hope to act as a bulwark against a federal committee bearing a similar name and its new members who believe that childhood vaccines can cause autism, despite the lack of evidence for such a link.
The Independent Autism Coordinating Committee (I-ACC) will hold its first meeting on March 19 — the same day that the newly-reformed federal body, the Interagency Autism Coordinating Committee (IACC), will meet for its first publicly-announced meeting, as first reported by the Washington Post.
The independent body’s leaders see their group and future actions as a direct rebuke of health secretary Robert F. Kennedy Jr. and his decision to refashion the federal body with members who align with his views on autism and vaccines, instead of preeminent researchers and autistic self-advocates.
“We don’t believe that the new federal IACC is going to pursue the kinds of areas and priorities that the mainstream scientific community feels are important at this point,” said Helen Tager-Flusberg, a member of the new group and director of the Center for Autism Research Excellence at Boston University.
The independent group includes many former members of the federal body, such as Joshua Gordon, former National Institute of Mental Health director, and Alison Singer, president of the Autism Science Foundation. The 12 members are mostly researchers, a contrast with the federal body, whose members mostly focus on advocacy.
Tager-Flusberg says the group will not rehash every matter the federal body considers, but they will primarily determine which topics within autism research deserve the most attention, with an eye on informing the decisions of non-governmental funders. The group will continue to meet whenever the federal body meets in an attempt to halt any misinformation that emerges from the meeting. If, for example, IACC plans to discuss vaccines and autism, the researchers will host a meeting and discuss the existing evidence on the topic on the same day.
When asked whether the similar names, meeting dates, and purported goals could sow confusion in the autism community about who to trust, she responded, “Are you going to pay attention to the group that contains not a single reputable scientist, or anyone experienced with conducting research? Or are you going to look at a group of people, which includes the people who have all the credentials that you would expect from the membership of the IACC?”
The Department of Health and Human Services has no plans to change the federal body’s proceedings in response to their independent counterpart. “The federal IACC will continue to fulfill President Trump’s directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment, and prevention,” said Andrew Nixon, an HHS spokesperson.
This is not the first group of researchers and advocates who have formed their own advisory group as a bid to push back against misinformation from the federal government. The Vaccine Integrity Project launched last year as a means for assessing and disseminating the best available evidence on vaccines.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














